SANTO has launched a new production of solid peroral medications
As part of the 135th anniversary celebration of the SANTO plant, a solemn ceremony of opening a new production unit for solid peroral medications was held in Shymkent. The launch of a new production with a capacity of 200 million tablets per year is another winning stage of a large-scale investment program, systematically implemented at the enterprise by an investor - the Polpharma Group.
In the festive event timed to the anniversary of the company, high guests - Akim of South Kazakhstan region and Shymkent Zh. Tuimebayev and G. Abdrakhimov, the main shareholders of SANTO, representatives of the governments of Poland and Kazakhstan, partners from related enterprises participated.
The new production unit was created in accordance with GMP (Good Manufacturing Practice) requirements for the production of pharmaceutical products. It is equipped with modern equipment, the personnel has been trained at the best production sites of the Polpharma Group. End of a new unit construction for the production of solid dosage forms at the cost of $ 13.5 million is an important part of the investment project in Shymkent. Thanks to the support of the state and regional authorities, SANTO has a guaranteed purchase amounts of its products.
We remind that, according to the investment program, the company has already launched a new production of medicines in ampoules, the production of infusion solutions in bags and bottles, two production units for the production of antibiotic powders, and also a warehouse of finished products and a research and testing center, a quality control laboratory, an infrastructure were moderenized, a new boiler house was built. The total cost of planned investments exceeds 108 million US dollars until 2020, to date, 70 million dollars have been spent.